| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 50.859 | 10.732 | 0 | 0 | 0 | 0 | 0 | 64.321 | 189.824 | 641.991 |
| Total Income - EUR | 50.881 | 10.732 | 0 | 0 | 0 | 0 | 0 | 64.342 | 189.824 | 641.991 |
| Total Expenses - EUR | 46.752 | 10.733 | 0 | 0 | 510 | 906 | 1.029 | 66.202 | 190.637 | 611.288 |
| Gross Profit/Loss - EUR | 4.129 | -1 | 0 | 0 | -510 | -906 | -1.029 | -1.860 | -813 | 30.703 |
| Net Profit/Loss - EUR | 2.602 | -323 | 0 | 0 | -510 | -906 | -1.029 | -2.503 | -855 | 25.592 |
| Employees | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
Check the financial reports for the company - Farmalact Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 18 | 18 | 18 | 17 | 17 | 462 | 243 | 34 | 3.652 | 2.503 |
| Current Assets | 11.022 | 9.072 | 8.919 | 8.755 | 8.918 | 7.779 | 7.414 | 96.443 | 90.415 | 147.254 |
| Inventories | 3.462 | 0 | 0 | 0 | 3.191 | 3.130 | 3.061 | 24.572 | 11.578 | 23.537 |
| Receivables | 4.506 | 3.992 | 3.925 | 3.853 | 4.199 | 4.357 | 4.409 | 11.528 | 37.942 | 120.409 |
| Cash | 3.053 | 5.080 | 4.994 | 4.902 | 1.528 | 292 | -56 | 60.342 | 40.895 | 3.308 |
| Shareholders Funds | 6.895 | 6.502 | 6.392 | 6.275 | 3.577 | 2.603 | 1.516 | 396 | -460 | 25.135 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.145 | 2.588 | 2.545 | 2.498 | 5.358 | 5.639 | 6.140 | 96.081 | 94.527 | 124.622 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4633 - 4633" | |||||||||
| CAEN Financial Year |
4633
|
|||||||||
Comments - Farmalact Srl